revolade
novartis europharm limited - eltrombopag - idiopaatiline, trombotsütopeeniline purpur - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
eltrombopag olainfarm õhukese polümeerikattega tablett
olainfarm as - eltrombopaag - õhukese polümeerikattega tablett - 12,5mg 84tk; 12,5mg 10tk; 12,5mg 28tk; 12,5mg 30tk; 12,5mg 14tk
eltrombopag olainfarm õhukese polümeerikattega tablett
olainfarm as - eltrombopaag - õhukese polümeerikattega tablett - 50mg 14tk
eltrombopag zentiva õhukese polümeerikattega tablett
zentiva k.s. - eltrombopaag - õhukese polümeerikattega tablett - 25mg 84tk; 25mg 28tk
eltrombopag olainfarm õhukese polümeerikattega tablett
olainfarm as - eltrombopaag - õhukese polümeerikattega tablett - 25mg 84tk; 25mg 28tk; 25mg 10tk
eltrombopag olainfarm õhukese polümeerikattega tablett
olainfarm as - eltrombopaag - õhukese polümeerikattega tablett - 75mg 14tk; 75mg 28tk; 75mg 84tk
doptelet
swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombotsütopeenia - antihemorraagilised ained - doptelet on näidustatud ravi raske trombotsütopeenia täiskasvanud patsientidel, kellel on krooniline maksahaigus, kes on kavandatud läbima invasiivne protseduur. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikosteroidid, immunoglobuliinid).
mulpleo (previously lusutrombopag shionogi)
shionogi b.v. - lusutrombopag - trombotsütopeenia - antihemorraagilised ained - mulpleo on näidustatud ravi raske trombotsütopeenia täiskasvanud patsientidel, kellel on krooniline maksahaigus läbivate invasiivsete protseduuride.
tavlesse
instituto grifols s.a. - fostamatinib dinaatrium - - trombotsütopeenia - muud süsteemse hemostatics - tavlesse on näidustatud ravi krooniliste immuunsüsteemi trombotsütopeenia (itp) täiskasvanud patsientidel, kes on tulekindlad teiste ravimitega.
bromocriptin-richter tablett
gedeon richter plc. - bromokriptiin - tablett - 2,5mg 30tk